PFSA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Profusa Inc (PFSA) is not a good buy at the moment for a beginner investor with a long-term strategy. The company is facing significant financial challenges, including a massive drop in net income and EPS. Additionally, the pre-market price trend is negative, and there are no strong technical or proprietary trading signals indicating a buy opportunity. While the company has plans for product launches and collaborations, these are long-term catalysts and do not align with the user's immediate investment goals.
The technical indicators are mixed but lean bearish. The MACD is positive and expanding, which is a bullish signal, but the RSI indicates the stock is oversold. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the pre-market price is below the key support level of S1 (0.903).
Collaboration with Mayo Clinic could also provide long-term growth opportunities.
is also down 1.31%. Financial performance is extremely weak, with a massive YoY decline in net income (-24439.47%) and EPS (-4660.87%).
In Q3 2025, the company reported zero revenue growth, a net income drop of -24439.47% YoY, and an EPS decline of -4660.87%. Gross margin remains at 0%. These figures indicate severe financial challenges and no immediate signs of recovery.
No analyst rating or price target changes are available for this stock.
